Theis Kipling
Förmögenhet: 209 594 $ per 2026-05-31
Förmögenhet: 209 594 $ per 2026-05-31
Theis Kipling is currently Chief Executive Officer at Biovica International AB since 2026.
Formerly, Mr. Kipling was Chief Commercial Officer at Devyser Diagnostics AB from 2022 to 2026 and Chief Commercial Officer at Atlas Antibodies AB.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DEVYSER DIAGNOSTICS AB 0,12 % | 2024-12-31 | 20 809 ( 0,12 % ) | 209 594 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Verkställande Direktör | 2026-05-01 |
| Företag | Position | Slut |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Företagsledare/Principal | 2026-05-01 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Biovica International AB
Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån